Dexamethasone for the Prophylaxis of Pain Flare Study
NCT00438828 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2014-11-19
Summary
Radiation treatment is often recommended as a safe and quick treatment that gives most people good relief from bone pain within a couple of weeks. However, some people can experience a short episode of increased pain (called a 'flare') a day or two after radiation treatment, that lasts about a day. The purpose of this sturdy is to find out if a medication called dexamethasone can help prevent pain flare as a result of radiation therapy.
Conditions
Interventions
- DRUG
-
8mg Dexamethasone PO on days 0 (prior to radiation treatment), and days 1, 2, and 3 following radiation treatment.
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
lead OTHER
Principal Investigators
-
Edward Chow, MBBS PhD · [email protected]
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- Canada
Study Locations
More Related Trials
-
Dexamethasone Dyspnea Study
NCT01670097 ·Status: COMPLETED ·Phase: PHASE2
-
Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction
NCT02349763 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
NCT06367725 ·Status: RECRUITING
-
Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer
NCT04350229 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone in Controlling Dyspnea in Patients With Cancer
NCT03367156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
NCT02382068 ·Status: WITHDRAWN ·Phase: NA
-
Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)
NCT02815319 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
NCT03839940 ·Status: TERMINATED ·Phase: PHASE3
-
Reducing Dexamethasone Around Docetaxel Infusion
NCT02776436 ·Status: COMPLETED ·Phase: PHASE1
-
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
NCT00152867 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy
NCT01209507 ·Status: COMPLETED
-
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
NCT07254416 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy).
NCT00193869 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Versus Intravenous Dexamethasone
NCT01390012 ·Status: COMPLETED ·Phase: PHASE3
-
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity
NCT03598426 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Infusion in Community-acquired Pneumonia
NCT00471640 ·Status: COMPLETED ·Phase: NA
-
Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer
NCT00507858 ·Status: COMPLETED ·Phase: PHASE1
-
Dexamethasone Therapy for Low Back Pain
NCT02965196 ·Status: UNKNOWN ·Phase: NA
-
Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer
NCT05564286 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
NCT03668639 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin
NCT04201769 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment
NCT06118710 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer
NCT02364804 ·Status: COMPLETED
-
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
NCT00293384 ·Status: COMPLETED ·Phase: NA
-
Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients
NCT00869973 ·Status: TERMINATED ·Phase: PHASE3